Therapy with canakinumab for gout

التفاصيل البيبلوغرافية
العنوان: Therapy with canakinumab for gout
المؤلفون: M. S. Eliseev, E. L. Nasonov
المصدر: Научно-практическая ревматология, Vol 56, Iss 0, Pp 41-48 (2019)
بيانات النشر: Mediar Press, 2019.
سنة النشر: 2019
مصطلحات موضوعية: musculoskeletal diseases, 0301 basic medicine, Drug, Acute arthritis, medicine.medical_specialty, Interleukin 1 family, media_common.quotation_subject, Immunology, Diseases of the musculoskeletal system, Disease, canakinumab, 03 medical and health sciences, gout, 0302 clinical medicine, Rheumatology, medicine, Immunology and Allergy, In patient, Intensive care medicine, media_common, 030203 arthritis & rheumatology, business.industry, medicine.disease, Gout, Canakinumab, 030104 developmental biology, RC925-935, interleukin 1β, Acute gouty arthritis, business, medicine.drug
الوصف: A significant part of patients with gout has contraindications to taking nonsteroidal anti-inflammatory drugs, colchicine and glucocorticoids. Such therapy is often ineffective, particularly in patients with the severe tophaceous gout what hampers treatment of acute arthritis attack assuming the need for other methods of therapy. During the last years several medications have been introduced the mechanism of anti-inflammatory action of which is associated with inhibition of interleukin 1 (IL1) playing a key role in the development of acute gouty arthritis. To date, the most well-studied and the only registered drug for relief of acute arthritis attack is canakinumab, recommended for use in situations where other therapy options are unacceptable. Despite these limitations, the use of IL1 inhibitors, in particular canakinumab, seems promising due to the high efficiency of the drug, the ability to use it in patients with comorbid diseases, as well as a favorable effect on the risk of cardiovascular disease.
تدمد: 1995-4492
1995-4484
DOI: 10.14412/1995-4484-2018-41-48
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5dc35e44ac1aae51daf3c0087e99a8d
https://doi.org/10.14412/1995-4484-2018-41-48
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....c5dc35e44ac1aae51daf3c0087e99a8d
قاعدة البيانات: OpenAIRE
الوصف
تدمد:19954492
19954484
DOI:10.14412/1995-4484-2018-41-48